Vasculitis: a review identifies differences in the gut microbiota without establishing causality

A synthesis covering several forms of vasculitis

The authors searched for publications available through May 2025 in four bibliographic databases: PubMed, Scopus, Medline and Web of Science. Their aim was to compare the gut microbiota profiles of people with vasculitis with those of healthy individuals.

Of the 12 publications included, three focused on Takayasu arteritis, three on ANCA-associated vasculitis and three on Behçet’s disease. The others covered IgA vasculitis, Kawasaki disease and an unspecified form of vasculitis.

The dossier provides access only to the PubMed abstract. It specifies neither the total number of participants, nor follow-up durations, nor the treatments received. The full text was not consulted.

Bacterial differences, without a quantified clinical effect

Most publications reported variations in microbiota diversity and richness, as well as differences in the composition of microbial communities between patients and controls.

The abstract notably mentions frequent decreases in major bacterial groups, including Bacteroidetes, Firmicutes and Proteobacteria. However, it provides neither a pooled numerical estimate of these differences nor a clinical outcome that would allow their importance for patients to be assessed directly.

These observations therefore do not, on their own, define a microbial signature that could be used to diagnose vasculitis or predict its course.

A research avenue, not an indication for treatment

The authors suggest that an imbalance in the microbiota could contribute to the onset or progression of vasculitis. This remains a biological hypothesis: the observed differences do not establish whether they precede the disease, result from it or reflect other factors.

The abstract reports no intervention demonstrating that targeting the microbiota improves vasculitis. This review therefore does not, on its own, justify using a supplement or making dietary changes for therapeutic purposes.

The diversity of the diseases grouped together also limits the scope of any general conclusion. Finally, the authors state that the review was not registered. Funding and conflicts of interest cannot be verified from the dossier provided.

What we can take away

This review supports an association between vasculitis and differences in the gut microbiota. It demonstrates neither that these differences cause the disease nor that correcting them provides a therapeutic benefit.